RNU2-44P

Across TCGA pan-cancer cohorts, RNU2-44P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU2-44P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU2-44P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU2-44P expression acts as an unfavorable survival marker.

STAD, MESO, and LIHC are the cancer types where RNU2-44P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.411	0.672	<.001	57	view →
MESO	OS	Tertile	All	0.018	0.559	<.001	36	view →
LIHC	DFS	Tertile	All	0.081	0.527	.012	27	view →
TGCT	OS	Tertile	All	0.771	0.968	.004	18	view →
KIRC	DFS	Tertile	IV	0.179	0.638	.038	18	view →
PRAD	OS	Tertile	All	0.870	0.990	<.001	18	view →
LAML	DFS	Tertile	All	0.165	0.581	.034	18	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU2-44P–STAD (DFS)

Open the STAD breakdown →